NCT07158398View on ClinicalTrials.gov

Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Participants
Interventions
DRUG

Vimseltinib

Administered orally

DRUG

Rosuvastatin

Administered orally

Trial Locations (1)

66212

RECRUITING

Dr. Vince Clinical Research, Overland Park

Sponsors
All Listed Sponsors
lead

Deciphera Pharmaceuticals, LLC

INDUSTRY

NCT07158398 - Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate | Biotech Hunter | Biotech Hunter